(Q36648906)

15 August 2017

Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging (English)

1 reference

15 August 2017

1 reference

1 reference

1

G Pellegriti

1 reference

15 August 2017

S Leboulleux

2

1 reference

15 August 2017

E Baudin

3

1 reference

15 August 2017

N Bellon

4

1 reference

15 August 2017

C Scollo

5

1 reference

15 August 2017

J P Travagli

6

1 reference

15 August 2017

M Schlumberger

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

88

1 reference

15 August 2017

10

1 reference

15 August 2017

1537-1542

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6600930

15 August 2017

0 references

cites work

Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Estimation of confidence limits for the cumulative probability of survival in life table analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2377113

Nonparametric Estimation from Incomplete Observations

20 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600930

Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival

21 January 2018

1 reference

12 December 2020

The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer

1 reference

12 December 2020

Medullary thyroid carcinoma: prognostic factors and treatment

1 reference

12 December 2020

Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content

1 reference

12 December 2020

Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization

1 reference

12 December 2020

Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register

1 reference

12 December 2020

Long-term follow-up of patients with medullary carcinoma of the thyroid

1 reference

12 December 2020

Surgical management of patients with persistent or recurrent medullary thyroid cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6600930

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

12771918

1 reference